Clonal heterogeneity of polymorphic B-cell lymphoproliferative disease, EBV-positive, iatrogenic/immune senescence: implications on pathogenesis and treatment

Clonal heterogeneity of polymorphic B-cell lymphoproliferative disease, EBV-positive, iatrogenic/immune senescence: implications on pathogenesis and treatment

Background Epstein Barr virus positive (EBV+) immunodeficiency-associated lymphoproliferative disorders (IA-LPD) are heterogeneous diseases with variable treatment strategies that are not well-defined.Case presentation A 68-year-old woman with systemic lupus erythematosus developed EBV+ B-cell polym...

Full description

Bibliographic Details
Main Authors: Yu-Yan Hwang, Rex Au-Yeung, Rock Y.Y. Leung, Eric Tse, Yok-Lam Kwong
Format: Article
Language:English
Published: Taylor & Francis Group 2022-12-01
Series:Hematology
Subjects:
EBV-positive
EBV-negative
lymphoproliferative disease
clonal heterogeneity
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2022.2081299

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2022.2081299

Similar Items